Plain-English translation of NCT07033975 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study looks at whether a Mediterranean diet — rich in fruits, vegetables, whole grains, and plant compounds called flavonoids — can help improve symptoms and slow disease progression in people with multiple sclerosis (MS). Researchers believe that what you eat can influence how MS develops, so this trial is testing whether this specific, healthier eating pattern makes a real difference for your disease.
Multiple sclerosis is affected by many factors, including nutrition and environmental choices. This study exists to find out whether dietary changes alone — without medication — can help support your health and potentially slow disease progression.
You likely qualify if…
You likely don't qualify if…
You would follow a flavonoid-enriched Mediterranean diet — focusing on plant-based foods like fruits, vegetables, legumes, nuts, and whole grains — while researchers track how your MS symptoms and disease markers change over time. The study will likely include regular check-ins and assessments to measure whether the diet affects your disease progression.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Belgium
Sponsor
Jerome J. A. Hendriks
Collaborators
Revalidatie & MS Centrum Overpelt
Enrollment target
~100 participants
Started
April 2023
Primary completion
December 2028
Age range
30 Years – 65 Years
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jerome JA Hendriks, Professor
Jerome J. A. Hendriks
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.